UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
--------------------
Date of report (Date of earliest event reported): March 17, 2006
Applied DNA Sciences, Inc
(Exact Name of Registrant as Specified in Charter)
Nevada 002-90539 59-2262718
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
25 Health Sciences Drive, Suite 113
Stony Brook, New York 11790
(Address of Principal Executive Offices) (Zip Code)
631-444-6862
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2 below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d- 2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e- 4(c))
Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
(d) Election of Directors. On March 17, 2006, the board of directors (the
"Board") of Applied DNA Sciences, Inc. (the "Company") increased the size of the
Board to six members and appointed the following new directors:
James Hayward, Chief Executive Officer of the Company;
Sanford R. Simon;
Yacov Shamash.
There are no arrangements or understandings between any of the new
directors and any other persons pursuant to which each person was selected as a
director. Board committee assignments have not yet been determined for the new
directors.
Item 8.01 Other Events.
In February 2005, the Company entered into an agreement with The Research
Foundation of the State University of New York acting on behalf of Stony Brook
University ("The Research Foundation") to support a project entitled "A Chimeric
Method and System for DNA Encryption and Authentication." Pursuant to this
agreement, the Research Foundation made a grant of $79,005.77 to the Company to
support the project, which amount is payable over six months. Upon approval from
The Research Foundation, the Company will receive an additional grant of
$80,000, payable over one year. The general objective of this project is to
further research of chimeric DNA methodology.
See the disclosure under Item 5.02 above.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Applied DNA Sciences, Inc.
(Registrant)
By: /s/ James Hayward
-----------------
James Hayward
Chief Executive Officer
Date: March 20, 2006